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Abstract
Age-related neurodegenerative diseases are great challenges as the aging population grows. To
promote neurodegeneration research and to share recent progress in understanding molecular
mechanisms underlying these devastating diseases, the journal Molecular Neurodegeneration and
Institute for Biomedical Research, Xiamen University co-organized the 2009 International
Conference on Molecular Neurodegeneration in Xiamen, China on May 18-20, 2009. The
objectives of this meeting were to (1) promote cutting-edge neurodegeneration research in China
and in neighboring Asian countries; (2) facilitate the exchange of information relevant to
neurodegenerative research; (3) provide education opportunity for students, postdocs and
physicians; and (4) provide a platform for investigators at different career levels to interact and
network, and to foster collaborations at the international levels. About 100 investigators presented
their recent discoveries with a wide range of scopes of neurodegeneration research, including new
genes, molecular pathways, animal models, and potential therapeutics.
Introduction
As life expectancy continues to increase and a growing
number of people enter the aged population, neurodegen-
erative diseases have increasingly become a major prob-
lem for which treatments are critically needed. Although
much progress has been made in the past 20 years on
understanding the mechanisms of neurodegenerative dis-
eases and on developing novel therapeutic strategies,
most of these achievements are from the United Stated
and European countries. Neurodegeneration research in
Asian countries, most of which are very populated and
also suffered severely with the spread of neurodegenera-
tive diseases, is lagged far behind. The 2009 International
Conference on Molecular Neurodegeneration is designed
to bridge this gap. The major aim of this meeting is to pro-
vide a unique platform for Asian researchers and scientists
from Western countries to exchange information and
ideas, to share their most recent research advances, and to
establish future collaborations in neurodegeneration
studies.
This conference is jointly sponsored by Molecular Neurode-
generation http://www.molecularneurodegeneration.com/
, an open access, peer-reviewed online journal that pub-
lishes all aspects of neurodegeneration research, and Insti-
tute for Biomedical Research, Xiamen University http://
biomed.xmu.edu.cn/, which is dedicated to revealing the
fundamental molecular causes of diseases and devising
the innovative therapies of tomorrow. Finacial supports of
this meeting come from both foundations and pharma-
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ceutical companies including Alzheimer's Association,
Ellison Medical Foundation, National Natural Science
Foundation of China, Science and Technology Bureau of
Xiamen City, Raptor Pharmaceutical, GlaxoSmithKline,
Beckman Coulter, Zeiss, Perkin Elmer, Millipore, Applied
Biosystems, and Genetimes Techonolgoy, Inc. Drs. Guo-
jun Bu from Washington University School of Medicine
and Huaxi Xu from Burnham Institute for Medical
Research, Editors-in-Chief of Molecular Neurodegeneration,
are co-chairs of this conference.
More than 20 world-renowned scientists, including Dr.
Aaron Ciechanover, a 2004 Nobel Laureate in Chemistry
for his discovery of the ubiquitin system, and Dr. Steven
Heinemann, a member of the US National Academy of
Sciences, presented their research progress in the meeting.
In addition, researchers from Asian countries, including
China (Mainland, Hong Kong, and Taiwan), Japan, and
South Korea, also presented their work in short talk and
poster sessions.
List of sessions, chairs, speakers and titles
See figure 1 for picture.
Session I & II Chair: Guojun Bu (USA)
• Keynote Speaker: Aaron Ciechanover (Israel Institute of
Technology, 2004 Nobel Laureate in Chemistry): "The
ubiquitin proteolytic system: from basic mechansisms
through human diseases and onto drug targeting"
Session I: ApoE and apoE receptors in AD
￿ Guojun Bu (Washington University School of Medi-
cine): "ApoE receptors in apoE and Aβ metabolism"
￿ Mary Jo LaDu (University of Illinois at Chicago): "Aβ42
and apoE structure/function interactions: implications for
Alzheimer's disease"
Session II: APP processing: β- and γ-secretases
￿ Robert Vassar (Northwestern University): "Regulation of
BACE1 in Alzheimer's disease"
￿ Takeshi Iwatsubo (University of Tokyo): "Alzheimer's
disease: unraveling the structure-function relationship of
gamma-secretase"
￿ Gopal Thinakaran (University of Chicago): "Function
and dysfunction of presenilins"
Session III & Short Talk Session I Chair: Huaxi Xu 
(Burnham Institute)
Session III: Presenilin and amyloid beta
￿ Sam Sisodia (University of Chicago): "Presenilin func-
tion in adult neurogenesis"
Short Talk Session I
￿ Taisuke Tomita (The University of Tokyo): "Identifica-
tion and analysis of a substrate-specific genetic modulator
for the γ-secretase activity"
photograph from the 2009 ICMN Figure 1
photograph from the 2009 ICMN.
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￿ Yingying Le (Institute for Nutritional Sciences, Chinese
Academy of Sciences): "Activation of β-adrenergic recep-
tor on microglia promotes uptake and clearance of Alzhe-
imer's disease-associated amyloid β peptide"
￿ Wandong Zhang (National Research Council of Can-
ada): "ABCG2 is up-regulated in Alzheimer's brain with
cerebral amyloid angiopathy and acts as a gatekeeper at
the blood-brain barrier for Aβ peptides"
Session IV, V & Short Talk Session II Chair: Sam Sisodia 
(University of Chicago)
Keynote Address- Steve Heinemann (Salk Institute): "New
approaches to understanding Alzheimer's disease"
Session IV: Functions of APP and its processing products
￿ Hui Zheng (Baylor College of Medicine): "APP function
in neurons and synapses"
￿ Frederic Checler (National Institute of Health and Med-
ical Research, France): "Regulatory functions of APP intra-
cellular domain"
Session V: Parkinson and trinucleotide repeat disorders
￿ Jie Shen (Harvard Medical School): "Impaired neuro-
transmitter release in Alzheimer's and Parkinson's dis-
eases"
￿ Xiaojiang Li (Emory University): "Synaptic toxicity of
mutant huntingtin"
Short Talk Session II
￿ Hongyu Hu (Shanghai Institutes for Biological Sciences,
Chinese Academy of Sciences): "Mechanism of α-synul-
cein aggregation associated with Parkinson's disease"
￿ Hua Gao (Key Laboratory for Neurodegenerative Dis-
ease of the Ministry of Education): "DJ-1 decrease roten-
one-mediated dopaminergic cell death via ERK signaling"
￿ Cristine Alves da Costa (Institut de Pharmacologie
Moleculaire et Cellulaire): "DJ-1-mediated cell death con-
trol by p53 is regulated by caspase proteolysis"
￿ Lingqiang Zhu (Department of Pathophysiology and
Hubei Provincial Key Laboratory of Neurological Dis-
eases): "Activation of glycogen synthase kinase-3 inhibits
long term potentiation with synapse-associated impari-
ments"
Session VI & Short Talk Session III Chair: Hui Zheng 
(Baylor College of Medicine)
Session VI: BDNF and novel genes in neurodegeneration
￿ Eric Tzeng (Beckman Coulter): "The latest total solution
characterizes neurodisorder diseases"
Yunwu Zhang (Xiamen University): "A novel gene that
inhibits Alzheimer's β-amyloid generation and tau phos-
phorylation"
Short Talk Session III
￿ Jin Tae Hong (College of Pharmacy, Chungbuk National
University): "Mutant presenilin 2 (N141I) increases beta-
secretase activity through increase of ERK pathway
dependent hydrogen peroxide generation"
￿ Ling Li (University of Alabama at Birmingham):"Simv-
astatin prevents cognitive and hippocampal synaptic def-
icits in APP/PS1 double transgenic mice"
￿ Wangxia Wang (University of Kentucky): "MicroRNA
miR-107 targets genes related to neurodegenerative dis-
ease"
￿ Qingyan Liu (National Research Council of Canada): "A
novel transmembrane protein down regulated in Alzhe-
imer's brains and interacts with a DnaJ-like heat shock
protein (DNAJB4)"
￿ Xiuqi Bao (Institute of Materia Medica, Chinese Acad-
emy of Medical Science and Peking Union Medical Col-
lege): "Establishment of gonadectomy-accelerated brain
aging model in mice"
Session VII & VIII Chair: Xiao-Jiang Li (Emory University)
Session VII: Metal, cell cycle and signaling in neurodegen-
eration
￿ Ashley Bush (University of Melbourne): "The metal the-
ory of Alzheimer's disease: from bench to clinic"
￿ Karl Herrup (Rutgers University): "Cell cycle events as
risks for neurodegeneration: a look into mechanism"
￿ Yong Shen (Sun Health Research Institute): "Tumor
necrosis factor and Alzheimer's disease"
Session VIII: AD genetics and therapy
￿ George Martin (University of Washington): "Classes of
gene action with the potential to modulate the times of
onset and the rates of progression of neurodegenerative
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￿ Edward Koo (University of California in San Diego):
"Gamma secretase modulators, nonsteroidal anti-inflam-
matory drugs, and Alzheimer's disease"
￿ Colin Masters (Mental Health Research Institute of Vic-
toria, Australia): "Aβ oligomers as tractable targets for
Alzheimer's disease: diagnostics and therapeutics"
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